Stephen Kron to Drug Design
This is a "connection" page, showing publications Stephen Kron has written about Drug Design.
Connection Strength
0.288
-
Telomerase reverse transcriptase degradation via a rationally designed covalent proteolysis targeting chimera. Bioorg Med Chem Lett. 2025 Sep 01; 125-126:130286.
Score: 0.220
-
Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. Nat Chem Biol. 2008 Jul; 4(7):418-24.
Score: 0.068